From Pasteur to genomics: progress and challenges in infectious diseases

[1]  Jean-Claude Laprie,et al.  Trend Analysis , 1996, The SAGE Encyclopedia of Research Design.

[2]  R. May,et al.  Plagues and peoples , 2006, IUBMB life.

[3]  Y. Guan,et al.  H 5 N 1 influenza : A protean pandemic threat , 2005 .

[4]  A. Barrett,et al.  West Nile virus: where are we now? , 2004, The Lancet. Infectious diseases.

[5]  A. Casadevall,et al.  Passive antibody therapy for infectious diseases , 2004, Nature Reviews Microbiology.

[6]  Sally Caglioti,et al.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. , 2004, The New England journal of medicine.

[7]  Elizabeth Miller,et al.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction , 2004, The Lancet.

[8]  D. Normile,et al.  Avian Influenza Makes a Comeback, Reviving Pandemic Worries , 2004, Science.

[9]  B. Murphy,et al.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.

[10]  R. Steinbrook.  The AIDS epidemic in 2004. , 2004, The New England journal of medicine.

[11]  A. Fauci,et al.  The challenge of emerging and re-emerging infectious diseases , 2004, Nature.

[12]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[13]  B. Cooper,et al.  Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Roberts.  Health Workers Scramble to Contain African Epidemic , 2004, Science.

[15]  Lawrence O Gostin,et al.  International infectious disease law: revision of the World Health Organization's International Health Regulations. , 2004, JAMA.

[16]  P. Minor,et al.  Polio eradication, cessation of vaccination and re-emergence of disease , 2004, Nature Reviews Microbiology.

[17]  J. Giles.  Tissue survey raises spectre of ‘second wave’ of vCJD , 2004, Nature.

[18]  R. Webster,et al.  H5N1 influenza: a protean pandemic threat. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Schrag,et al.  Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. , 2004, JAMA.

[20]  Kenneth H Buetow,et al.  Bioinformatics Tools for Single Nucleotide Polymorphism Discovery and Analysis , 2004, Annals of the New York Academy of Sciences.

[21]  B. Moss,et al.  Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  O. White,et al.  Environmental Genome Shotgun Sequencing of the Sargasso Sea , 2004, Science.

[23]  MJ Walters.  Six Modern Plagues , 2004, Environmental Health Perspectives.

[24]  G. Boivin,et al.  Human Metapneumovirus: A New Player among Respiratory Viruses , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Michael Greenberg,et al.  Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes , 2004, Nature Reviews Drug Discovery.

[26]  D. Philpott,et al.  Innate immunity via Toll-like receptors and Nod proteins. , 2004, Current opinion in microbiology.

[27]  J. Shiver,et al.  Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. , 2004, Annual review of medicine.

[28]  P. Formenty,et al.  Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife , 2004, Science.

[29]  L. Roberts.  Polio. Health workers scramble to contain African epidemic. , 2004, Science.

[30]  F. Schmidt,et al.  The challenge of multidrug resistance: actual strategies in the development of novel antibacterials , 2004, Applied Microbiology and Biotechnology.

[31]  D. Harris.  Mad Cow Disease and Related Spongiform Encephalopathies , 2004, Current Topics in Microbiology and Immunology.

[32]  K. Howard.  Unlocking the money-making potential of RNAi , 2003, Nature Biotechnology.

[33]  R. Rappuoli,et al.  SARS — beginning to understand a new virus , 2003, Nature Reviews Microbiology.

[34]  E. Cascales,et al.  The versatile bacterial type IV secretion systems , 2003, Nature Reviews Microbiology.

[35]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[36]  Pauline Chu,et al.  Protective immunity against Helicobacter is characterized by a unique transcriptional signature , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Masahiro Yamamura,et al.  Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease , 2003, Science.

[38]  R. Koup,et al.  Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates , 2003, Nature.

[39]  D. Webster,et al.  Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans , 2003, Nature Medicine.

[40]  F. Lowy.  Antimicrobial resistance: the example of Staphylococcus aureus. , 2003, The Journal of clinical investigation.

[41]  M. Pedro-Botet,et al.  Legionella spp.: community acquired and nosocomial infections , 2003, Current opinion in infectious diseases.

[42]  S. Kleinman,et al.  Current and emerging infectious risks of blood transfusions. , 2003, JAMA.

[43]  Rino Rappuoli,et al.  Reverse vaccinology. , 2000, Current opinion in microbiology.

[44]  C. Wheeler,et al.  A controlled trial of a human papillomavirus type 16 vaccine. , 2002, The New England journal of medicine.

[45]  Henryk Mach,et al.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity , 2002, Nature.

[46]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[47]  E. De Clercq,et al.  Strategies in the design of antiviral drugs , 2002, Nature reviews. Drug discovery.

[48]  S. Levy.  Antibiotic resistance: consequences of inaction. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  N. Andrews,et al.  Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England , 2001, The Lancet.

[50]  C. Yim.  Understanding hepatitis C. , 2001, CANNT journal = Journal ACITN.

[51]  C. Vitek,et al.  Diphtheria in the Russian Federation in the 1990s. , 2000, The Journal of infectious diseases.

[52]  R C George,et al.  Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis , 2000, BMJ : British Medical Journal.

[53]  R. Rappuoli.  Reverse vaccinology : Genomics , 2000 .

[54]  M. Houghton.  Strategies and prospects for vaccination against the hepatitis C viruses. , 2000, Current topics in microbiology and immunology.

[55]  B. Lidbury,et al.  Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. , 2000, The Journal of infectious diseases.

[56]  G. Cornelis,et al.  Assembly and function of type III secretory systems. , 2000, Annual review of microbiology.

[57]  D. Relman.  The search for unrecognized pathogens. , 1999, Science.

[58]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[59]  D. Pfarr,et al.  Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. , 1997, The Journal of infectious diseases.

[60]  R. Rappuoli,et al.  Cellular Microbiology Emerging , 1996, Science.

[61]  R. Fleischmann,et al.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. , 1995, Science.

[62]  Christopher J. L. Murray,et al.  Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.

[63]  D. Relman,et al.  Identification of the uncultured bacillus of Whipple's disease. , 1992, The New England journal of medicine.

[64]  Cholera , 1868, Current Topics in Infectious Disease.

[65]  R. Rappuoli,et al.  Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. , 1992, Vaccine.

[66]  J. Weeks.  AIDS epidemic. , 1992, The National medical journal of India.

[67]  Behring Von Stabsarzt,et al.  Ueber das zustandekommen der diphtherie-immunität und der tetanus-immunität bei thieren☆ , 1991 .

[68]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[69]  Behring,et al.  Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren , 1890 .